ID Database Citation 11313942 Pubmed "PRCC, the commonest TFE3 fusion partner in papillary renal carcinoma is associated with pre-mRNA splicing factors. Skalsky YM, Ajuh PM, Parker C, Lamond AI, Goodwin G, Cooper CS. Oncogene. 2001 Jan 11;20(2):178–87. PubMed Europe PMC Scholia" 17211469 Pubmed "HIF and fumarate hydratase in renal cancer. Sudarshan S, Linehan WM, Neckers L. Br J Cancer. 2007 Feb 12;96(3):403–7. PubMed Europe PMC Scholia" 19422821 Pubmed "The renal cell carcinoma-associated oncogenic fusion protein PRCCTFE3 provokes p21 WAF1/CIP1-mediated cell cycle delay. Medendorp K, van Groningen JJM, Vreede L, Hetterschijt L, Brugmans L, van den Hurk WH, et al. Exp Cell Res. 2009 Aug 15;315(14):2399–409. PubMed Europe PMC Scholia" 25048860 Pubmed "Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers. Kauffman EC, Ricketts CJ, Rais-Bahrami S, Yang Y, Merino MJ, Bottaro DP, et al. Nat Rev Urol. 2014 Aug;11(8):465–75. PubMed Europe PMC Scholia" 26536169 Pubmed "Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. Cancer Genome Atlas Research Network, Linehan WM, Spellman PT, Ricketts CJ, Creighton CJ, Fei SS, et al. N Engl J Med. 2016 Jan 14;374(2):135–45. PubMed Europe PMC Scholia"